Mineralocorticoid receptor mutations differentially affect individual gene expression profiles in pseudohypoaldosteronism type 1

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 3, 2011, Pages

  Fernandes Rosa, Fábio L ^a,b,c   Hubert, Edwige Ludiwyne ^b,c   Fagart, Jérome ^b,e   Tchitchek, Nicolas ^f   Gomes, Debora ^a   Jouanno, Elodie ^c,d   Benecke, Arndt ^f   Rafestin Oblin, Marie Edith ^b,c   Jeunemaitre, Xavier ^b,c,d   Antonini, Sonir R ^a   Zennaro, Maria Christina ^b,c,d  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSERM   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^e UNIVERSITÉ PARIS SACLAY   (France)

^f INSTITUT DES HAUTES ÉTUDES SCIENTIFIQUES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; EPITHELIAL SODIUM CHANNEL; GLUCOCORTICOID INDUCED LEUCINE ZIPPER PROTEIN; LEUCINE; LEUCINE ZIPPER PROTEIN; MINERALOCORTICOID RECEPTOR; N MYC DOWNSTREAM REGULATORY GENE 2; PROLINE; REGULATOR PROTEIN; RETROVIRUS VECTOR; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; UNCLASSIFIED DRUG;

ALPHA HELIX; ARTICLE; BETA SHEET; BINDING AFFINITY; CIS TRANS ISOMERISM; COMPLEX FORMATION; CONTROLLED STUDY; CRYSTAL STRUCTURE; FAMILY STUDY; GENE; GENE ACTIVATION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LIGAND BINDING; NR3C2 GENE; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PSEUDOHYPOALDOSTERONISM; PSEUDOHYPOALDOSTERONISM TYPE 1; REPORTER GENE; SITE DIRECTED MUTAGENESIS; STRUCTURE ANALYSIS; TRANSCRIPTION REGULATION; WILD TYPE;

ALDOSTERONE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HETEROZYGOTE; HUMANS; MODELS, MOLECULAR; MUTATION; PEDIGREE; PLASMIDS; PROTEIN BIOSYNTHESIS; PSEUDOHYPOALDOSTERONISM; RECEPTORS, MINERALOCORTICOID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; TRANSCRIPTIONAL ACTIVATION;

MOUSE MAMMARY TUMOR VIRUS;

EID: 79952299315     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-1486     Document Type: Article

References (40)

1. Verrey F, Pearce D, Pfeiffer R, Spindler B, Mastroberardino L, Summa V, Zecevic M 2000 Pleiotropic action of aldosterone in epithelia mediated by transcription and post-transcription mechanisms. Kidney Int 57:1277-1282 (Pubitemid 30207878)
2. Viengchareun S, Le Menuet D, Martinerie L, Munier M, Pascual-Le Tallec L, Lombès M 2007 The mineralocorticoid receptor: insights into its molecular and (patho)physiological biology. Nucl Recept Signal 5:e012
3. Rogerson FM, Fuller PJ 2003 Interdomain interactions in the mineralocorticoid receptor. Mol Cell Endocrinol 200:45-55 (Pubitemid 36335805)
4. Liu W, Wang J, Yu G, Pearce D 1996 Steroid receptor transcriptional synergy is potentiated by disruption of the DNA-binding domain dimer interface. Mol Endocrinol 10:1399-1406 (Pubitemid 26423230)
5. Fagart J, Huyet J, Pinon GM, Rochel M, Mayer C, Rafestin-Oblin ME 2005 Crystal structure of a mutant mineralocorticoid receptor responsible for hypertension. Nat Struct Mol Biol 12:554-555 (Pubitemid 43085888)
6. Bledsoe RK, Madauss KP, Holt JA, Apolito CJ, Lambert MH, Pearce KH, Stanley TB, Stewart EL, Trump RP, Willson TM, Williams SP 2005 A ligand-mediated hydrogen bond network required for the activation of the mineralocorticoid receptor. J Biol Chem 280:31283-31293 (Pubitemid 41291866)
7. Li Y, Suino K, Daugherty J, Xu HE 2005 Structural and biochemical mechanisms for the specificity of hormone binding and coactivator assembly by mineralocorticoid receptor. Mol Cell 19:367-380 (Pubitemid 41074892)
8. Huyet J, Pinon GM, Fay MR, Fagart J, Rafestin-Oblin ME 2007 Structural basis of spirolactone recognition by the mineralocorticoid receptor. Mol Pharmacol 72:563-571 (Pubitemid 47347291)
9. Zennaro MC, Lombès M 2004 Mineralocorticoid resistance. Trends Endocrinol Metab 15:264-270 (Pubitemid 39044200)
10. Chang SS, Grunder S, Hanukoglu A, Rösler A, Mathew PM, Hanukoglu I, Schild L, Lu Y, Shimkets RA, Nelson-Williams C, Rossier BC, Lifton RP 1996 Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1. Nat Genet 12:248-253 (Pubitemid 26080082)
11. Geller DS, Rodriguez-Soriano J, Vallo Boado A, Schifter S, Bayer M, Chang SS, Lifton RP 1998 Mutations in the mineralocorticoid receptor gene cause autosomal dominant pseudohypoaldosteronism type I. Nat Genet 19:279-281 (Pubitemid 28309343)
12. Pujo L, Fagart J, Gary F, Papadimitriou DT, Claës A, Jeunemaître X, Zennaro MC 2007 Mineralocorticoid receptor mutations are the principal cause of renal type 1 pseudohypoaldosteronism. Hum Mutat 28:33-40 (Pubitemid 46036212)
13. Fernandes-Rosa FL, de Castro M, Latronico AC, Sippell WG, Riepe FG, Antonini SR 2006 Recurrence of the R947X mutation in unrelated families with autosomal dominant pseudohypoaldosteronism type 1: evidence for a mutational hot spot in the mineralocorticoid receptor gene. J Clin Endocrinol Metab 91:3671-3675 (Pubitemid 44402154)
14. Sartorato P, Lapeyraque AL, Armanini D, Kuhnle U, Khaldi Y, Salomon R, Abadie V, Di Battista E, Naselli A, Racine A, Bosio M, Caprio M, Poulet-Young V, Chabrolle JP, Niaudet P, De Gennes C, Lecornec MH, Poisson E, Fusco AM, Loli P, Lombès M, Zennaro MC 2003 Different inactivating mutations of the mineralocorticoid receptor in fourteen families affected by type I pseudohypoaldosteronism. J Clin Endocrinol Metab 88:2508-2517 (Pubitemid 36724416)
15. Sartorato P, Khaldi Y, Lapeyraque AL, Armanini D, Kuhnle U, Salomon R, Caprio M, Viengchareun S, Lombès M, Zennaro MCC 2004 Inactivating mutations of the mineralocorticoid receptor in type I pseudohypoaldosteronism. Mol Cell Endocrinol 217:119-125 (Pubitemid 38596636)
16. Riepe FG, Krone N, Morlot M, Peter M, Sippell WG, Partsch CJ 2004 Autosomal-dominant pseudohypoaldosteronism type 1 in a Turkish family is associated with a novel nonsense mutation in the human mineralocorticoid receptor gene. J Clin Endocrinol Metab 89:2150-2152 (Pubitemid 38619845)
17. Jones TA, Zou JY, Cowan SW, Kjeldgaard M 1991 Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr A 47:110-119
18. Vandewalle A, Lelongt B, Geniteau-Legendre M, Baudouin B, Antoine M, Estrade S, Chatelet F, Verroust P, Cassingena R, Ronco P 1989 Maintenance of proximal and distal cell functions in SV40- transformed tubular cell lines derived from rabbit kidney cortex. J Cell Physiol 141:203-221 (Pubitemid 19243628)
19. Prié D, Friedlander G, Coureau C, Vandewalle A, Cassingéna R, Ronco PM 1995 Role of adenosine on glucagon-induced cAMP in a human cortical collecting duct cell line. Kidney Int 47:1310-1318
20. Claire M, Rafestin-Oblin ME, Michaud A, Corvol P, Venot A, Roth-Meyer C, Boisvieux JF, Mallet A 1978 Statistical test of models and computerized parameter estimation for aldosterone binding in rat kidney. FEBS Lett 88:295-299 (Pubitemid 8320543)
21. Couette B, Jalaguier S, Hellal-Levy C, Lupo B, Fagart J, Auzou G, Rafestin-Oblin ME 1998 Folding requirements of the ligand-binding domain of the human mineralocorticoid receptor. Mol Endocrinol 12:855-863 (Pubitemid 30659059)
22. Rogerson FM, Yao YZ, Elsass RE, Dimopoulos N, Smith BJ, Fuller PJ 2007 A critical region in the mineralocorticoid receptor for aldosterone binding and activation by cortisol: evidence for acommon mechanism governing ligand binding specificity in steroid hormone receptors. Mol Endocrinol 21:817-828 (Pubitemid 46991956)
23. Morel F, Doucet A 1986 Hormonal control of kidney functions at the cell level. Physiol Rev 66:377-468 (Pubitemid 16055844)
24. Náray-Fejes-Tóth A, Fejes-Tóth G 2000 The sgk, an aldosterone-induced gene in mineralocorticoid target cells, regulates the epithelial sodium channel. Kidney Int 57:1290-1294
25. Soundararajan R, Zhang TT, Wang J, Vandewalle A, Pearce D 2005 A novel role for glucocorticoid-induced leucine zipper protein in epithelial sodium channel-mediated sodium transport. J Biol Chem 280:39970-39981 (Pubitemid 41779132)
26. Boulkroun S, Fay M, Zennaro MC, Escoubet B, Jaisser F, Blot-Chabaud M, Farman N, Courtois-Coutry N 2002 Characterization of rat NDRG2 (N-Myc downstream regulated gene 2), a novel early mineralocorticoid-specific induced gene. J Biol Chem 277:31506-31515
27. Pippal JB, Yao Y, Rogerson FM, Fuller PJ 2009 Structural and functional characterization of the interdomain interaction in the mineralocorticoid receptor. Mol Endocrinol 23:1360-1370
28. Curtis SW, Shi H, Teng C, Korach KS 1997 Promoter and species specific differential estrogen-mediated gene transcription in the uterus and cultured cells using structurally altered agonists. J Mol Endocrinol 18:203-211 (Pubitemid 27278394)
29. Hall JM, McDonnell DP, Korach KS 2002 Allosteric regulation of estrogen receptor structure, function, and coactivator recruitment by different estrogen response elements. Mol Endocrinol 16:469-486 (Pubitemid 34214567)
30. Lesne A, Benecke A 2008 Probability landscapes for integrative genomics. Theor Biol Med Model 5:9
31. Caprio M, Fève B, Claës A, Viengchareun S, Lombès M, Zennaro MC 2007 Pivotal role of the mineralocorticoid receptor in corticosteroid-induced adipogenesis. FASEB J 21:2185-2194 (Pubitemid 47026453)
32. Szapary D, Huang Y, Simons Jr SS 1999 Opposing effects of corepressor and coactivators in determining the dose-response curve of agonists, and residual agonist activity of antagonists, for glucocorticoid receptor-regulated gene expression. Mol Endocrinol 13:2108-2121 (Pubitemid 30637270)
33. Murai-Takeda A, Shibata H, Kurihara I, Kobayashi S, Yokota K, Suda N, Mitsuishi Y, Jo R, Kitagawa H, Kato S, Saruta T, Itoh H 2010 NF-YC functions as a corepressor of agonist-bound mineralocorticoid receptor. J Biol Chem 285:8084-8093
34. Riepe FG 2009 Clinical and molecular features of type 1 pseudohypoaldosteronism. Horm Res 72:1-9
35. Náray-Fejes-Tóth A, Canessa C, Cleaveland ES, Aldrich G, Fejes- Tóth G 1999 sgk is an aldosterone-induced kinase in the renal collecting duct. Effects on epithelial na+ channels. J Biol Chem 274:16973-16978
36. Robert-Nicoud M, Flahaut M, Elalouf JM, Nicod M, Salinas M, Bens M, Doucet A, Wincker P, Artiguenave F, Horisberger JD, Vandewalle A, Rossier BC, Firsov D 2001 Transcriptome of a mouse kidney cortical collecting duct cell line: effects of aldosterone and vasopressin. Proc Natl Acad Sci USA 98:2712-2716 (Pubitemid 32209548)
37. Tajima T, Kitagawa H, Yokoya S, Tachibana K, Adachi M, Nakae J, Suwa S, Katoh S, Fujieda K 2000 A novel missense mutation of mineralocorticoid receptor gene in one Japanese family with a renal form of pseudohypoaldosteronism type 1. J Clin Endocrinol Metab 85:4690-4694 (Pubitemid 32157653)
38. Sartorato P, Cluzeaud F, Fagart J, Viengchareun S, Lombès M, Zennaro MC 2004 New naturally occurring missense mutations of the human mineralocorticoid receptor disclose important residues involved in dynamic interactions with deoxyribonucleic acid, intracellular trafficking, and ligand binding. Mol Endocrinol 18:2151-2165 (Pubitemid 39215247)
39. Riepe FG, Finkeldei J, de Sanctis L, Einaudi S, Testa A, Karges B, Peter M, Viemann M, Grötzinger J, Sippell WG, Fejes-Toth G, Krone N 2006 Elucidating the underlying molecular pathogenesis of NR3C2 mutants causing autosomal dominant pseudohypoaldosteronism type 1. J Clin Endocrinol Metab 91:4552-4561
40. Balsamo A, Cicognani A, Gennari M, Sippell WG, Menabò S, Baronio F, Riepe FG 2007 Functional characterization of naturally occurring NR3C2 gene mutations in Italian patients suffering from pseudohypoaldosteronism type 1. Eur J Endocrinol 156:249-256 (Pubitemid 46554520)